Long-term Cardiac Monitoring in Epilepsy
Stopped early · Not applicable
Conditions studied: Focal Epilepsy, Intractable Epilepsy, Epileptic Encephalopathy, Lennox Gastaut Syndrome, Symptomatic Epilepsy, Generalized Epilepsy
In brief
The purpose of this research study to investigate, classify, and quantify chronic cardiac rhythm disorders in three groups of patients with epilepsy (intractable focal epilepsy, controlled focal epilepsy and symptomatic generalized epilepsy). Patients with epilepsy have a higher risk for cardiac complications than the general population. With this study, we aim to understand more about these potential complications in patients with epilepsy and assess if treatments for cardiac problems should be evaluated more carefully in patients with epilepsy.
Key facts
- Study ID
- NCT03955432
- Run by
- Northwell Health
- People needed
- 7
- Starts
- 2019-03-19
- Expected to finish
- 2023-01-03
- Last updated by the study team
- 2023-02-08
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18-50 years with ability to consent.
- No primary cardiac abnormality.
- Ability to receive an implantable loop recorder and tolerate the procedure.
- Patients with epilepsy as described by the three groups (intractable focal epilepsy, controlled focal epilepsy and symptomatic generalized epilepsy)
You may not qualify if…
- Cardiac disease of any type
- Known epilepsy genetic disorder with potential cardiac compromise
- Major co-morbidities such as cancer, diabetes, stroke, bleeding disorder
- Chronic psychosis
- Severe MR without reliable caregiver monitoring (what is MR?)
- Already included in another clinical trial that will affect the objectives of this study.
- Life expectancy is less than 1 year
Where it is running
- Northwell — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.